NEXT Oncology - Dallas — Irving, Texas

NEXT Oncology - Dallas is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Oncology - Dallas has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Carcinoma, High Grade Endometrial Carcinoma.

Sponsors: Boundless Bio, Inc., Kumquat Biosciences Inc., MediLink Therapeutics (Suzhou) Co., Ltd..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology - Dallas?

NEXT Oncology - Dallas has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology - Dallas conducted?

NEXT Oncology - Dallas has 5 clinical trials on record, with 4 currently active. Their work covers Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Carcinoma, High Grade Endometrial Carcinoma.

Is NEXT Oncology - Dallas accredited by Crixeo Health?

Yes — NEXT Oncology - Dallas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Oncology - Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.